Cumberland Pharmaceuticals Inc. Operating Lease, Liability, Noncurrent
Cumberland Pharmaceuticals Inc. (CPIX) had Operating Lease, Liability, Noncurrent of $4.21 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Noncurrent $4.21M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $4.34M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $4.47M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $4.60M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $4.21M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.34M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $4.47M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $4.60M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $4.71M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.83M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $4.94M 10-K · filed 2026-03-09 |
| 2024-09-30 | $5.00M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $5.10M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $5.20M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $5.30M 10-K · filed 2025-03-07 |
| 2023-09-30 | $5.39M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.48M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $4.55M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $4.59M 10-K · filed 2024-03-13 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $22.71K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $90.02K 10-K · filed 2023-03-13 |
| 2021-09-30 | $229.60K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $512.32K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $789.20K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.06M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.32M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.58M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.83M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $2.08M 10-K · filed 2021-03-12 |
| 2019-09-30 | $2.32M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.50M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.61M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |